PRLog - Feb. 12, 2013 - CHICAGO -- Both The American Center for Cures and Cures Within Reach were formed to cut through delays in the current medical research system to deliver cures and treatments to patients as quickly and effectively as possible, and see joint opportunities to make that acceleration happen on multiple levels.
American Center for Cures
The American Center for Cures (ACC), founded by entrepreneur and businessman Lou Weisbach and physician Dr. Richard Boxer, will open a new pathway to discovery and focus on the single most important goal that we have for our loved ones with an illness: CURES. As the co-founders said in a Huffington Post Article, “The National Institutes of Health (NIH) has made remarkable discoveries about the fundamentals of biology. But the time has come to apply that knowledge. The NIH basic research is essential in finding the pieces of the puzzle. The ACC will put the puzzle together. It's time America used its genius, once again, to proactively do the right thing for its citizens and the world.” In the next 45 days in Washington, a bipartisan bill will be announced to create the ACC, changing the economics of healthcare in America forever and bringing the brilliance of American business to focus on prevention and cures. Columnist, Author and Political Analyst James Pinkerton featured the ACC in his “Serious Medicine Strategy” blogpost in August of 2010, commenting on their work as a reminder that “the ultimate point of medicine is not finance, but medicine.”
The American Center for Cures, in concept, will be a public/private research institute within the NIH, led by a Director of Cures, a cabinet-level position and including 7 iconic leaders of the American industry, 3 representative of the American military leadership, the secretary of the HHS and the Director of the NIH. The director will oversee the cooperation of all existing governmental research entities and healthcare assets with the ACC as appropriate. The ACC will fund high-risk/high-
Cures Within Reach has been helping patients since 2005 by repurposing drugs and devices to deliver fast, safe and affordable treatments and cures for both common and rare disorders without effective treatments. By creating a network of relationships with research institutions and funders around the country, Cures Within Reach has been able to source, select and fund pilot clinical research projects that test existing drugs and devices for new purposes, or combine existing treatments in new ways. This research is often overlooked because it lacks profit incentive, doesn’t provide career advancement for researchers and can be perceived as “uninteresting”
With similar goals and complementary tactics, The American Center for Cures and Cures Within Reach are striving for patient-centered changes in the medical research system. The fundraising arm of The American Center for Cures will be housed within Cures Within Reach, a 501c3 public charity, so that donations will be tax deductible. The Cures Within Reach staff will work with The American Center for Cures founders to deploy these funds, accelerating the public support for and the initiation of The American Center for Cures.
For more information about these organizations, see